CGMP-specific phosphodiesterase type 5

Results: 69



#Item
41HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, f

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA® (sildenafil citrate) tablets, f

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-03-11 11:17:40
42June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU

June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU

Add to Reading List

Source URL: www.mt-pharma.co.jp

Language: English - Date: 2013-06-27 01:00:46
431 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIALIS safely and effectively. See full prescribing information for CIALIS. CIALIS (tadalafil) tablets, for oral u

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-30 17:40:11
44LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION

LEVITRA® (vardenafil HCl) TABLETS[removed]DESCRIPTION

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:45:49
45CIALIS®  1 ANL 5215 AMP  (tadalafil)

CIALIS® 1 ANL 5215 AMP (tadalafil)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:45:47
46Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology:

Pfizer Mechanism of Action PF[removed]PDE5 inhibitor Selective, competitive and reversible PDE5 inhibitor IUPHAR/BPS Guide to pharmacology:

Add to Reading List

Source URL: www.ncats.nih.gov

Language: English - Date: 2014-05-12 12:58:36
47HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVATIO safely and effectively. See full prescribing information for REVATIO. REVATIO (sildenafil) tablets, for oral

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVATIO safely and effectively. See full prescribing information for REVATIO. REVATIO (sildenafil) tablets, for oral

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-03-21 13:39:52
48DEPARTMENT OF HEALTH & HUMAN SERVICES  Public Health Service Food and Drug Administration Rockville, MD 20857

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857

Add to Reading List

Source URL: www.fda.gov

Language: English
49Australian Public Assessment Report for Tadalafil

Australian Public Assessment Report for Tadalafil

Add to Reading List

Source URL: www.tga.gov.au

Language: English - Date: 2013-12-04 21:21:29
50CHAPTER 1  AL PHOSPHODIESTERASES AND CYCLIC NUCLEOTIDE SIGNALING IN THE CNS

CHAPTER 1 AL PHOSPHODIESTERASES AND CYCLIC NUCLEOTIDE SIGNALING IN THE CNS

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2014-02-28 07:14:26